Fukushima, Japan

Kaoru Gengyou


Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kaoru Gengyou: Innovator in Cyclic Amine Compounds

Introduction

Kaoru Gengyou is a notable inventor based in Fukushima, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of substituted cyclic amine compounds. His work focuses on creating compounds that can aid in the treatment of various circulatory organ-related diseases.

Latest Patents

Gengyou holds a patent for a substituted cyclic amine compound, which is represented by a specific general formula. This compound is designed to prevent and treat diseases such as hypertension, ischemic heart disease, cerebrovascular disease, and peripheral circulatory disease. The patent highlights the synthetic methods for producing this innovative compound, which has the potential to improve health outcomes for patients suffering from these conditions. He has 1 patent to his name.

Career Highlights

Gengyou is currently employed at Toa Eiyo Ltd., where he continues to engage in research and development of pharmaceutical compounds. His expertise in medicinal chemistry has positioned him as a valuable asset to the company and the broader scientific community.

Collaborations

Throughout his career, Gengyou has collaborated with esteemed colleagues such as Tsuyoshi Aoki and Atsuo Takahashi. These partnerships have fostered a collaborative environment that enhances innovation and the development of new therapeutic solutions.

Conclusion

Kaoru Gengyou's contributions to the field of cyclic amine compounds demonstrate his commitment to advancing medical science. His innovative work has the potential to significantly impact the treatment of circulatory diseases, showcasing the importance of research and collaboration in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…